UC San Diego School of Medicine, Continuing Medical Education
(858) 534-3940 | ocme@ucsd.edu | cme.ucsd.edu
home faculty agenda accreditation location registration supporters exhibitors contacts

The 4th Annual UC San Diego Essentials and Advances in Apheresis will build on the great success of the first three conferences. The 2½-day multidisciplinary program is designed to appeal to first time attendees and to returning participants. Expert reviews of the essentials will be augmented with selected new topics and discussions of advances and innovations. The course will include nationally and internationally recognized leaders that will present didactic sessions and conduct interactive discussions.

Fundamentals will include in-depth reviews of basic principles, procedures, prescribing, clinical management, and care of special populations. There will be updates on selected disease indications will be supplemented by case studies and new clinical science. In addition, we will review plasma exchange, cell apheresis modalities, technology innovations, billing practices, and program management. The popular concurrent sessions on Frontiers in Apheresis Science and Expertise in Apheresis Practice will continue and feature new topics sessions. Furthermore, attendees will be offered hands-on workshops, led by experienced practitioners, with small-group instructions of various techniques used in therapeutic apheresis. There is also a unique opportunity for attendees to participate in the Breakfast with the Experts, which will provide them a forum to pursue specific questions and detailed discussions on various areas of interest.

Target Audience

The target audience for this initiative includes physicians and allied health professionals interested in therapeutic apheresis, including both established practitioners and those embarking on a new apheresis service. The content is aimed at nephrologists, hematologists, clinical pathologists, blood bankers and nurses.

Overall Program Objectives

After completing the didactic sessions, participants should be able to:

  • Define the spectrum of therapeutic apheresis modalities and equipment.
  • Review current clinical indications for therapeutic plasmapheresis, photopheresis and other cytapheresis procedures, per ASFA guidelines.
  • Discuss options for vascular access, anticoagulation, and prescription for the various apheresis techniques, and their associated complications.
  • Describe the differences between centrifugal and membrane plasma separation and the use of selective secondary plasma processing.
  • Identify the use of apheresis in pediatrics, stem cell transplantation, and other special patient populations.
  • Discuss apheresis program management issues, including reimbursement.
  • Recognize recent developments and the future of apheresis medicine.

Workshop Learning Objectives

For each workshop session completed, the participant should be able to:

  • Distinguish the apheresis modalities that can be performed by different types of apheresis equipment, such as centrifugal machines, membrane separators, secondary plasma purification and cell processing systems.
  • Describe the blood pathway configuration of each machine studied, and the operator-controlled adjustments that are typically needed.
  • Discuss the typical blood flow rate, anticoagulation and vascular access requirements of each machine studied.

The 4th Annual UC San Diego Essentials and Advances in Apheresis Therapies is endorsed by: asfa

Follow UC San Diego CME on    UCSD CME facebook    UCSD CME twitter

UC San Diego School of Medicine, Continuing Medical Education   •  9500 Gilman Drive, MC0947   •  La Jolla, CA 92093-0947
Phone: (858) 534-3940   •   Toll-Free: (888) 229-6263   •   Fax: (858) 534-1896   •  E-mail: ocme@ucsd.edu   •  Website: cme.ucsd.edu

Content is subject to change without notice. Please refer to the activity website for the most current information.
Official website of the University of California, San Diego. Copyright ©2016 Regents of the University of California. All rights reserved.